Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37019909.
- Also identified by DOI 10.1038/s41467-023-37559-w and PMC identifier 10074357.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Resident memory T cells (T<sub>RM</sub>) present at the respiratory tract may be essential to enhance early SARS-CoV-2 viral clearance, thus limiting viral infection and disease. While long-term antigen-specific T<sub>RM</sub> are detectable beyond 11 months in the lung of convalescent COVID-19 patients, it is unknown if mRNA vaccination encoding for the SARS-CoV-2 S-protein can induce this frontline protection. Here we show that the frequency of CD4<sup>+</sup> T cells secreting IFNγ in response to S-peptides is variable but overall similar in the lung of mRNA-vaccinated patients compared to convalescent-infected patients. However, in vaccinated patients, lung responses present less frequently a T<sub>RM</sub> phenotype compared to convalescent infected individuals and polyfunctional CD107a<sup>+</sup> IFNγ<sup>+</sup> T<sub>RM</sub> are virtually absent in vaccinated patients. These data indicate that mRNA vaccination induces specific T cell responses to SARS-CoV-2 in the lung parenchyma, although to a limited extend. It remains to be determined whether these vaccine-induced responses contribute to overall COVID-19 control.
Medical subject headings
- SARS-CoV-2
- COVID-19